Evolve Private Wealth’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
38,016
+529
+1% +$25.8K 0.13% 149
2026
Q1
$1.61M Sell
37,487
-6,565
-15% -$282K 0.09% 229
2025
Q4
$1.93M Buy
+44,052
New +$1.82M 0.11% 169

Other funds holding EXEL

Evolve Private Wealth's EXEL Position: Q2 2026 in Review

Evolve Private Wealth increased its Exelixis (EXEL) stake by 1.4% in Q2 2026, buying an estimated $25.8K and bringing the position to 38,016 shares worth $2.07M. The position accounts for 0.13% of the portfolio, ranked #149.

Evolve Private Wealth first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Evolve Private Wealth held 38,016 shares of Exelixis worth $2.07M as of Q2 2026.
  • Evolve Private Wealth bought 529 Exelixis shares in Q2 2026, an estimated $25.8K.
  • Exelixis made up 0.13% of Evolve Private Wealth's portfolio in Q2 2026, its #149 holding.
  • Evolve Private Wealth first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.